calcimimetic peptide
Etelcalcetide clinical trials
Answer
Etelcalcetide has 24 registered trials: 3 running, 19 completed, 1 stopped early. 16 posted results.
Trial registerClinicalTrials.gov and EU CTIS, read 2026-10-03
| Trial | Title | Status | Phase | Registered | Results |
|---|---|---|---|---|---|
| NCT03969329 Trial register | A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis | currently recruiting participants | - | 2019-05-31 | - |
| NCT06690242 Trial register | MT1013 Injection for the Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease | completed | - | 2024-11-15 | - |
| 2023-506471-10-00 Trial register | Phase 3, Single-arm, Open-label, Multidose, Titration, Pharmacokinetic, Pharmacodynamic, and Safety Study of Etelcalcetide in Children and Adolescents ≥ 2 to < | Not stated | 3 | - | - |
| NCT03633708 Trial register | A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis | currently recruiting participants | - | 2018-08-16 | - |
| NCT06352957 Trial register | Use of ETElcalcetidefor pReserving vitamiN K-dependent proteIn activiTY ITAlian Study | not yet recruiting participants | - | 2024-04-08 | - |
| NCT03960437 Trial register | The Effect of Etelcalcetide on CKD-MBD | completed | - | 2019-05-23 | Posted |
| NCT03795558 Trial register | A Study to Investigate the Influence of PTH-lowering by Etelcalcetide (Parsabiv®) on the Calcification Propensity of Serum in Dialysis Patients | completed | - | 2019-01-07 | - |
| NCT03299244 Trial register | Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) | completed | - | 2017-10-03 | Posted |
| NCT03182699 Trial register | Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis Patients | completed | - | 2017-06-09 | - |
| NCT03527511 Trial register | Effect of Active Vitamin D and Etelcalcetide on Human Osteoclasts in Patients With Chronic Kidney Disease | completed | - | 2018-05-17 | - |
| NCT03283098 Trial register | A Phase 1 Study to Evaluate PK, Safety and Tolerability of AMG 416 | completed | - | 2017-09-14 | Posted |
| NCT01785849 Trial register | Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on Hemodialysis | completed | - | 2013-02-07 | Posted |
| NCT01788046 Trial register | Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodia | completed | - | 2013-02-11 | Posted |
| NCT01896232 Trial register | Head-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet | completed | - | 2013-07-11 | Posted |
| NCT02833857 Trial register | A Single-dose Study in Paediatric Patients Aged 2 to Less Than 18 Years With Secondary Hyperparathyroidism (sHPT) Receiving Haemodialysis | completed | - | 2016-07-14 | Posted |
| NCT01785875 Trial register | Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis | completed | - | 2013-02-07 | Posted |
| NCT01932970 Trial register | Study to Assess the Impact on Calcium Levels When Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) Switch From Cinacalcet to Etelcalcetide | completed | - | 2013-08-30 | Posted |
| NCT02054572 Trial register | Pharmacokinetics and Excretion of [¹⁴C]Etelcalcetide (AMG 416) in Patients With End Stage Renal Disease (ESRD) Receiving Dialysis | completed | - | 2014-02-04 | Posted |
| NCT01134562 Trial register | Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism | completed | - | 2010-06-02 | Posted |
| NCT02102204 Trial register | Extension Study of Etelcalcetide for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on Hemodialysis | completed | - | 2014-04-02 | Posted |
| NCT01134549 Trial register | Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Healthy Male Volunteers | completed | - | 2010-06-02 | Posted |
| NCT01254565 Trial register | Safety, Tolerability and Efficacy of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism | completed | - | 2010-12-06 | Posted |
| NCT01576146 Trial register | Open-label Study to Assess the Long-term Safety and Efficacy of Etelcalcetide (Also Known as AMG 416 or KAI-4169) in Patients With Secondary Hyperparathyroidism | terminated before completion | - | 2012-04-12 | Posted |
| NCT01414114 Trial register | Etelcalcetide to Treat Secondary Hyperparathyroidism in Hemodialysis Patients With Chronic Kidney Disease-Mineral and Bone Disorder | completed | - | 2011-08-11 | Posted |
Source: ClinicalTrials.gov and EU CTIS, read 2026-10-03. Not medical advice.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.